AlphaYou
Overview
Smart money at a glance
Filings to Oct 5, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: net selling of $15K to $50K in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- -$15K to -$50K netNet selling
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 2 added, 0 cutMore adding
Market overview
Fundamentals Sep 13- Open
- $84.95
- 52-wk high
- $85.01
- High
- $84.95
- 52-wk low
- $32.30
- Low
- $84.95
- Prev close
- $84.95
- Mkt cap
- $9.01B
- Volume
- 0
- Beta
- 0.09
- P/S
- 213.8x
- P/B
- 7.6x
- Profit margin
- +0.0%
- Op margin
- -527.0%
- ROE
- -42.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CRNX filings
Are insiders buying or selling Crinetics Pharmaceuticals Inc (CRNX) stock?
Neither. Crinetics Pharmaceuticals Inc (CRNX) insiders filed no open-market purchases or sales in the 90 days to Oct 5, 2026, according to SEC Form 4 filings.
Which members of Congress have traded CRNX recently?
Rep. Gilbert Cisneros (D) sold $15K to $50K on Jul 30, 2026, disclosed 36 days later. In total, 1 member disclosed 1 CRNX trade with trade dates in the last 180 days, filed a median 36 days after trading.
How current is this CRNX smart-money data?
This summary uses filings available on Oct 5, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (2)
- MW
Marshall Wace
$17.3M
added
- BO
Bank of America
$23.9M
added
Sells/Trims (1)
- P7
Point72
$108.8M
sold
What insiders are doing
What Congress is doing
Sells (1)
How top traders are positioned
No tracked top-trader positions in CRNX right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 7.3% above what analysts expected.
Last report
Aug 3, 2026
Period ending
Jun 30, 2026
Earnings per share
-$1.23 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 3, 2026 | -$1.14 / -$1.23Alpha Vantage | +7.32% beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 7, 2026 | -$1.23 / -$1.20Alpha Vantage | -2.50% miss | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 26, 2026 | -$1.29 / -$1.37Alpha Vantage | +5.84% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | -$1.38 / -$1.25Alpha Vantage | -10.40% miss | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | -$1.23 / -$1.13Alpha Vantage | -8.85% miss | Unavailable | Unavailable |
| Mar 31, 2025 | May 8, 2025 | -$1.04 / -$0.95Alpha Vantage | -9.47% miss | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 27, 2025 | -$0.88 / -$0.89Alpha Vantage | +1.33% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 12, 2024 | -$0.96 / -$0.91Alpha Vantage | -5.49% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
What the street expects next
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $143.0K | $6.2M | $10.7M | $25.1M |
| Cost of what it sold | $90.5M | -$459.0K | $200.0K | $154.0K |
| Gross profit | $143.0K | $6.2M | $10.5M | $25.0M |
| What it spent | ||||
| Research and development | $90.5M | $85.1M | $100.1M | $99.8M |
| Sales and admin | $52.3M | $53.7M | $50.8M | $57.6M |
| Total operating expenses | $142.7M | $139.8M | $150.9M | $157.4M |
| What was left | ||||
| Operating profit | -$142.6M | -$133.7M | -$140.4M | -$132.5M |
| Profit before tax | -$130.1M | -$122.6M | -$127.8M | -$120.9M |
| Tax | — | $180.0K | — | — |
| Net profit | -$130.1M | -$122.8M | -$127.8M | -$120.9M |
| EBITDA | -$129.1M | -$121.6M | -$126.7M | -$131.4M |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace